Pharmaceutical Brand Protection & Anti-Counterfeiting
June 18-20, 2019 | Switzerland
With sales of falsified, substandard and counterfeit pharmaceuticals estimated at around $200 billion annually, the illicit pharmaceutical market tops the luxury goods, alcohol and even tobacco industry’s illicit sales as the most lucrative imitation market. Such a profitable market continues to attract specialist counterfeiters and organised crime, making it clear that challenge of illicit pharmaceuticals is only growing despite public and private efforts.